enVVeno Medical Corporation Warrants
NVNOW
NVNOW was delisted on the 26th of May, 2023.
1 hedge funds and large institutions have $3K invested in enVVeno Medical Corporation Warrants in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
50% more capital invested
Capital invested by funds: $2K → $3K (+$1K)
0% more funds holding
Funds holding: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.3K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $3K | +$1.3K | +2,400 | +63% |
|
NVNOW Hedge Fund Activity: Q4 2018 in Review
1 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical Corporation Warrants (NVNOW) for Q4 2018, worth a combined $3K — up 50% from $2K a quarter earlier.
Fund positioning in NVNOW was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $1.3K.
- 1 institutional investor held enVVeno Medical Corporation Warrants (NVNOW) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $3K of enVVeno Medical Corporation Warrants stock for Q4 2018, up 50% quarter-over-quarter.
- 0 funds opened new enVVeno Medical Corporation Warrants positions in Q4 2018 and 0 closed out.
- The largest enVVeno Medical Corporation Warrants buyer in Q4 2018 was UBS Group, an estimated $1.3K added.
Based on aggregated 13F filings for Q4 2018.